University of Miami leads groundbreaking trial for COVID-19 treatment

(University of Miami Miller School of Medicine) University of Miami Miller School of Medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest COVID-19 patients, according to results published in STEM CELLS Translational Medicine in January 2021.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news